Development of INRASTES research activities in the framework of the National Research and Technology Strategy for Smart Specialization (MIS 5002559).
(Radio)diagnostic - (Radio)therapeutic Peptides and Peptide-like Molecules for Use in Oncology
Phase I clinical trial using a novel CCK-2/gastrin receptor-localizing radiolabelled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma
Improved Tumor Targeting with Radiolabeled Peptidomimetics
Development of Radiometalated GRPR-Antagonists for Tumor Diagnosis and Therapy
New SST2R-antagonists in the diagnosis of neuroendocrine tumors with PET/CT
Radiolabeled Vectors in Nuclear Oncology
